September 2024

SOUTH SAN FRANCISCO, Calif., Sept. 22, 2024 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that the company plans to issue a pre-market press release and conduct a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: